Janet Gunzburg Sells 1,709 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) insider Janet Gunzburg sold 1,709 shares of Phreesia stock in a transaction dated Monday, April 8th. The stock was sold at an average price of $22.62, for a total value of $38,657.58. Following the sale, the insider now directly owns 38,900 shares in the company, valued at $879,918. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Janet Gunzburg also recently made the following trade(s):

• On Tuesday, March 19th, Janet Gunzburg sold 2,817 shares of Phreesia stock. The stock was sold at an average price of $23.27, for a total value of $65,551.59.
• On Friday, February 9th, Janet Gunzburg sold 480 shares of Phreesia stock. The shares were sold at an average price of $28.00, for a total value of $13,440.00.
• On Thursday, February 1st, Janet Gunzburg sold 328 shares of Phreesia stock. The stock was sold at an average price of $25.99, for a total value of $8,524.72.
• On Friday, January 12th, Janet Gunzburg sold 205 shares of Phreesia stock. The shares were sold at an average price of $24.11, for a total transaction of $4,942.55.

Phreesia Stock Up 2.1 %

Phreesia stock opened at $23.80 on Friday. The stock has a 50-day simple moving average of $24.76 and a 200 day simple moving average of $21.09. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.02. Phreesia, Inc. has a 12-month low of $12.05 and a 12-month high of $34.98.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Thursday, March 14th. The company reported ($0.56) earnings per share for the quarter, beating the consensus estimate of ($0.58) by $0.02. Phreesia had a negative net margin of 38.42% and a negative return on equity of 53.33%. The firm had revenue of $95.00 million during the quarter, compared to analysts’ expectations of $93.52 million. During the same quarter last year, the company posted ($0.72) EPS. The company’s quarterly revenue was up 24.0% compared to the same quarter last year. On average, equities research analysts predict that Phreesia, Inc. will post -1.48 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have recently weighed in on PHR. DA Davidson reissued a “neutral” rating and issued a $32.00 target price on shares of Phreesia in a research note on Friday, March 15th. Robert W. Baird upped their price objective on Phreesia from $30.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, March 18th. Royal Bank of Canada restated a “sector perform” rating and set a $23.00 target price on shares of Phreesia in a research report on Thursday, March 21st. JMP Securities upped their price target on Phreesia from $28.00 to $30.00 and gave the company a “market outperform” rating in a research report on Thursday, March 21st. Finally, Canaccord Genuity Group increased their price objective on Phreesia from $36.00 to $37.00 and gave the stock a “buy” rating in a research note on Friday, March 15th. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $31.62.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. CI Investments Inc. increased its stake in shares of Phreesia by 6.6% in the 3rd quarter. CI Investments Inc. now owns 477,265 shares of the company’s stock valued at $8,915,000 after buying an additional 29,500 shares during the period. Schroder Investment Management Group acquired a new stake in Phreesia in the third quarter worth about $6,514,000. TimesSquare Capital Management LLC raised its holdings in Phreesia by 7.8% during the 3rd quarter. TimesSquare Capital Management LLC now owns 774,079 shares of the company’s stock worth $14,460,000 after purchasing an additional 55,793 shares during the last quarter. Lazard Asset Management LLC lifted its position in Phreesia by 58.6% during the 3rd quarter. Lazard Asset Management LLC now owns 424,047 shares of the company’s stock valued at $7,921,000 after purchasing an additional 156,711 shares during the period. Finally, Trust Point Inc. bought a new position in shares of Phreesia in the 4th quarter valued at about $239,000. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.